Skip to main content Accessibility help
  • Print publication year: 2019
  • Online publication date: December 2018

Chapter 9 - Posterior Pituitary

Ball, S G. (2017). The neurohypophysis: Endocrinology of vasopressin and oxytocin.
Ball, S G & Iqbal, Z. (2016). Diagnosis and treatment of hyponatraemia. Best Prac Res Clin Endocr Metab 30, 161173.
Christ-Crain, M, Morgenthaler, N G & Fenske, W. (2016). Copeptin as a biomarker and a diagnostic tool in the evaluation of patients with polyuria-polydipsia and hyponatremia. Best Prac Res Clin Endocr Metab 30, 235247.
Leng, G & Sabatier, N. (2016). Measuring oxytocin and vasopressin: bioassays, immunoassays and random numbers. J Neuroendocr 28, 113.
Afsar, B. (2017). Pathophysiology of copeptin in kidney disease and hypertension. Clin Hypertension 23, 13.
Babey, M, Kopp, P & Robertson, G L. (2011). Familial forms of diabetes insipidus: clinical and molecular characteristics. Nat Revs Endocr 7, 701714.
Ball, S G. (2017). The neurohypophysis: endocrinology of vasopressin and oxytocin.
Barber, S M, Liebelt, B D & Baskin, D S. (2014). Incidence, etiology and outcomes of hyponatremia after transsphenoidal surgery: experience with 344 consecutive patients at a single tertiary center. J Clin Med 3, 11991219.
Baskaran, C, Plessow, F, Silva, L et al. (2017). Oxytocin secretion is pulsatile in men and is related to social-emotional functioning. Psychoneuroendocr 85, 2834.
Berl, T. (2015). Vasopressin antagonists. New Engl J Med 372, 22072216.
Bershad, A K, Kirkpatrick, M G, Seiden, J A & de Wit, H. (2015). Effects of acute doses of prosocial drugs methamphetamine and alcohol on plasma oxytocin levels. J Clin Psychopharmacol 35, 308312.
Besser, G M & Thorner, M O. (2002). Comprehensive Clinical Endocrinology, 3rd Edition (St. Louis, MO: Mosby).
Bhandari, SS, Loke, I, Davies, JE, Squire, IB, Struck, J & Ng, LL. (2009). Gender and renal function influence plasma levels of copeptin in healthy individuals. Clin Sci 116, 257263.
Blevins, J E, Graham, J L, Morton, G J et al. (2015). Chronic oxytocin administration inhibits food intake, increases energy expenditure, and produces weight loss in fructose-fed obese rhesus monkeys. Am J Physiol 308, R431R438.
Boccia, M L, Petrusz, P, Suzuki, K, Marson, L & Pedersen, C A. (2013). Immunohistochemical localization of oxytocin receptors in human brain. Neurosci 253, 155164.
Brimdyr, K, Cadwell, K, Widström, A-M et al. (2015). The association between common labor drugs and suckling when skin-to-skin during the first hour after birth. Birth 42, 319328.
Burckhardt, M A, Wellmann, M, Fouzas, S et al. (2014). Sexual disparity of copeptin in healthy newborn infants. J Clin Endocr Metab 99, E1750E1753.
Capatina, C, Paluzzi, A, Mitchell, R & Karavitaki, N. (2015). Diabetes insipidus after traumatic brain injury. J Clin Med 4, 14481462.
Carmichael, M S, Humbert, R, Dixen, J, Palmisano, G, Greenleaf, W & Davidson, J M. (1987). Plasma oxytocin increases in the human sexual response. J Clin Endocr Metab 64, 2731.
Chard, T. (1989). Fetal and maternal oxytocin in human parturition. Am J Perinatol 6, 145152.
Christ-Crain, M & Fenske, W. (2016). Copeptin in the diagnosis of vasopressin-dependent disorders of fluid homeostasis. Nat Revs Endocr 12,168176.
Cobo, E. (1973). Effect of different doses of ethanol on the milk-ejecting reflex in lactating women. Am J Obs Gynecol 115, 817821.
Coiro, V, Alboni, A, Gramellini, D et al. (1992 ). Inhibition by ethanol of the oxytocin response to breast stimulation in normal women and the role of endogenous opioids. Acta Endocr 126, 213216.
de Jong, T R, Menon, R, Bludau, A et al. (2015). Salivary oxytocin concentrations in response to running, sexual self-stimulation, breastfeeding and the TSST: the Regensburg Oxytocin Challenge (ROC) study. Psychoneuroendocr 62, 381388.
Dudás, B, Semeniken, K R & Merchenthaler, I. (2006). Morphological substrate of the catecholaminergic input of the vasopressin neuronal system in humans. J Neuroendocr 18, 895901.
Dumais, K M & Veenema, A H. (2016). Vasopressin and oxytocin receptor systems in the brain: sex differences and sex-specific regulation of social behavior. Front Neuroendocr 40, 123.
Fenske, W, Sandner, B & Christ-Crain, M. (2016). A copeptin-based classification of the osmoregulatory defects in the syndrome of inappropriate antidiuresis. Best Prac Res Clin Endocr Metab 30, 219233.
Fenske, W K, Schnyder, I, Koch, G et al. (2018a). Release and decay kinetics of copeptin vs AVP in response to osmotic alterations in healthy volunteers. J Clin Endocr Metab 103, 505513.
Fenske, W, Refardt, J, Chifu, I et al. (2018b). A copeptin-based approach in the diagnosis of diabetes insipidus. New Engl J Med 379, 428439.
Freeman, S M, Smith, A L, Goodman, M M & Bales, K L. (2017). Selective localization of OXYtocin receptors and vasopressin 1a receptors in the human brainstem. Social Neurosci 12, 113123.
Fuchs, A R, Romero, R, Keefe, D, Parra, M, Oyarzun, E & Behnke, E. (1991). Oxytocin secretion and human parturition: pulse frequency and duration increase during spontaneous labor in women. Am J Obstet Gynecol 165, 15151523.
Fuxe, K, Andersson, K, Eneroth, P, Härfstrand, A & Agnati, L F. (1989). Neuroendocrine actions of nicotine and of exposure to cigarette smoke: medical implications. Psychoneuroendocr 14, 1941.
Giel, K, Zipfel, S & Hallschmid, M. (2017). Oxytocin and eating disorders: a narrative review on emerging findings and perspectives. Curr Neuropharmacol 16, 11111121.
Hammer, M & Engell, H C. (1982). Episodic secretion of vasopressin in man. Acta Endocr 101, 517523.
Hrabovszky, E, Kallo, I, Steinhauser, A, Merchenthaler, I, Coen, C W, Petersen, S L & Liposits, Z. (2004). Estrogen receptor-β in oxytocin and vasopressin neurons of the rat and human hypothalamus: immunocytochemical and in situ hybridization studies. J Comp Neurol 473, 315333.
Iovino, M, Giagulli, V A, Licchelli, B, Iovino, E, Guastamacchia, E & Triggiani, V. (2016). Synaptic inputs of neural afferent pathways to vasopressin- and oxytocin-secreting neurons of supraoptic and paraventricular hypothalamic nuclei. Endocr Metab Imm Disord: Drug Targets 16, 276287.
Ishunina, T A & Swaab, D F. (1999). Vasopressin and oxytocin neurons of the human supraoptic and paraventricular nucleus; size changes in relation to age and sex. J Clin Endocr Metab 84, 46374644.
Jean-Alphonse, F, Perkovska, S, Frantz, M-C et al. (2009). Biased agonist pharmacochaperones of the AVP V2 receptor may treat congenital nephrogenic diabetes insipidus. J Am Soc Nephrol 20, 21902203.
Jordan, D, Tafani, J A M, Ries, C et al. (1996). Evidence for multiple opioid receptors in the human posterior pituitary. J Neuroendocr 8, 883887.
Kendrick, K M, Guastella, A J & Becker, B. (2017). Overview of human oxytocin research. Curr Topics Behav Neurosci 35, 321348.
Kim, S H, Bennett, P R & Terzidou, V. (2017). Advances in the role of oxytocin receptors in human parturition. Mol Cell Endocr 449, 5663.
Kirkpatrick, M G, Francis, S M, Lee, R, de Wit, H & Jacob, S. (2014). Plasma oxytocin concentrations following MDMA or intranasal oxytocin in humans. Psychoneuroendocr 46, 2331.
Krüger, T H C, Haake, P, Chereath, D et al. (2003). Specificity of the neuroendocrine response to orgasm during sexual arousal in men. J Endocr 177, 5764.
Lawson, E A. (2017). The effects of oxytocin on eating behaviour and metabolism in humans. Nat Revs Endocr 13, 700709.
Lawson, E A, Marengi, D A, DeSanti, R L, Holmes, T M, Schoenfeld, D A & Tolley, C J. (2015). Oxytocin reduces caloric intake in men. Obesity 23, 950956.
Lee, R, Garcia, F, van de Kar, L D, Hauger, R D & Coccaro, E F. (2003). Plasma oxytocin in response to pharmaco-challenge to D-fenfluramine and placebo in healthy men. Psych Res 118, 129136.
Leng, G & Ludwig, M. (2016). Intranasal oxytocin: myths and delusions. Biol Psych 79, 243250.
Lewandowski, K C & Brabant, G. (2016). Potential clinical utility of copeptin (C-terminal provasopressin) measurements in clinical medicine. Exp Clin Endocr Diabetes 124, 173177.
Libber, S, Harrison, H & Spector, D. (1986). Treatment of nephrogenic diabetes insipidus with prostaglandin synthesis inhibitors. J Pediatr 108, 305311.
Lucas, J W & Zada, G. (2012). Imaging of the pituitary and parasellar region. Semin Neurol 32, 320331.
McNeilly, A S, Robinson, I C, Houston, M J & Howie, P W. (1983). Release of oxytocin and prolactin in response to suckling. Br Med J 286, 257259.
Meyer-Lindenberg, A, Domes, G, Kirsch, P & Heinrichs, M. (2011). Oxytocin and vasopressin in the human brain: social neuropeptides for translational medicine. Nat Revs Neurosci 12, 524538.
Miller, G. (2013). The promise and perils of oxytocin. Science 339, 267269.
Morgenthaler, N G, Struck, J, Jochberger, S & Dünser, M W. (2008). Copeptin: clinical use of a new biomarker. Trends Endocr Metab 19, 4349.
Morris, M S, Domino, E F & Domino, S E. (2010). Opioid modulation of oxytocin release. J Clin Pharmacol 50, 11121117.
Nissen, E, Uvnäs-Moberg, K, Svensson, K, Stock, S, Widström, A-M & Winberg, J. (1996). Different patterns of oxytocin, prolactin but notcortisol release during breastfeeding in women delivered by Caesarean section or by the vaginal route. Early Hum Develop 45, 103118.
Olszewski, P K, Klockars, A & Levine, A S. (2017). Oxytocin and potential benefits for obesity treatment. Curr Opin Endocr Diabetes Obes 24, 320325.
Ott, V, Finlayson, G, Lehnert, H et al. (2013). Oxytocin reduces reward-driven food intakein humans. Diabetes 62, 34183425.
Olza-Fernández, I, Gabriel, M A N, Gil-Sanchez, A, Garcia-Segura, L M & Arevalo, M A. (2014). Neuroendocrinology of childbirth and mother–child attachment: the basis of an etiopathogenic model of perinatal neurobiological disorders. Front Neuroendocr 35, 459472.
Parker, K J, Oztan, O, Libove, R A et al. (2017). Intranasal oxytocin treatment for social deficits and biomarkers of response in children with autism. Proc Nat Acad Sci USA 114, 81198124.
Radant, A, Peskind, E R, Wilkinson, C W et al. (1992). Neurohypophyseal and pituitary-adrenocortical responses to the alpha-1 agonist methoxamine in humans. Neuroendocr 55, 361366.
Robertson, G L. (2006). Regulation of arginine vasopressin in the syndromeof inappropriate antidiuresis. Am J Med 119, S36S42.
Rondon-Berrios, H & Berl, T. (2016). Vasopressin receptor antagonists: characteristics and clinical role. Best Prac Res Clin Endocr Metab 30, 289303.
Rondon-Berrios, H & Berl, T. (2017). Vasopressin receptor antagonists in hyponatremia: uses and misuses. Front Med 4, 141.
Scantamburlo, G, Hansenne, M, Fuchs, S et al. (2005). AVP- and OT-neurophysins response to apomorphine and clonidine in major depression. Psychoneuroendocr 30, 839845.
Semeniken, K, Merchenthaler, I, Hua, W & Dudás, B. (2009). Catecholaminergic input to the oxytocin neurosecretory system in the human hypothalamus. J Chem Neuroanat 37, 229233.
Shen, H. (2015). The hard science of oxytocin. Nature 522, 410412.
Shilling, P D & Feifel, D. (2016). Potential of oxytocin in the treatment of schizophrenia. CNS Drugs 30, 193208.
Simmler, L D, Hysek, C M & Liechti, M E. (2011). Sex differences in the effects of MDMA (ecstasy) on plasma copeptin in healthy subjects. J Clin Endocr Metab 96, 28442850.
Sladek, C D & Kapoor, J R. (2001). Neurotransmitter/neuropeptide interactions in the regulation of neurohypophyseal hormone release. Exp Neurol 171, 200209.
Sofroniew, M V, Weindl, A, Schrell, U & Wetzstein, R. (1981). Immunohistochemistry of vasopressin, oxytocin and neurophysin in the hypothalamus and extrahypothalamic regions of the human and primate brain. Acta Histochem Suppl 24, 7995.
Sukhov, R R, Walker, L C, Rance, N E, Price, D L & Young, WS III. (1993). Vasopressin and oxytocin gene expression in the human hypothalamus. J Comp Neurol 337, 295306.
Tauber, M, Boulanouar, K, Diene, G et al. (2017). The use of oxytocin to improve feeding and social skills in infants with Prader–Willi syndrome. Pediatrics 139, e20162976.
Ueda, T, Yokoyama, Y, Irahara, M & Aono, T. (1994). Influence of psychological stress on suckling-induced pulsatile oxytocin secretion. Obstet Gynecol 84, 259262.
Vasicka, A, Kumaresan, P, Hans, G S & Kumaresan, M. (1978). Plasma oxytocin in initiation of labor. Am J Obstet Gynecol 130, 263273.
Vuong, C, Van Uum, S H M, O’Dell, L E, Lutfy, K & Friedman, T C. (2010). The effects of opioids and opioid analogs on animal and human endocrine systems. Endocr Revs 31, 98132.
Weiskopf, R B, Reid, I A, Fisher, D M, Holmes, M A, Rosen, J I & Keil, L C. (1987). Effects of fentanyl on vasopressin secretion in human subjects. J Pharmacol Exp Therap 242, 970973.
Wood, C M, Butler, R J, Penney, M D & Holland, P C. (1994). Pulsatile release of arginine vasopressin (AVP) and its effect on response to desmopressin in enuresis. Scand J Urol Nephrol Suppl 163, 93101.
Young, L J & Barrett, C E. (2015). Can oxytocin treat autism? Science 347, 825826.
Zhang, H, Wu, C, Chen, Q, Chen, X, Xu, Z, Wu, J & Cai, D. (2013). Treatment of obesity and diabetes using oxytocin or analogs in patients and mouse models. PLoS ONE 8, e61477.